The Ivermectin and Covid-19 conundrum

In conclusion, the above implications are basically saying there is lack of good evidence for IVM in Covid-19. There is evidence also that IVM does not work for Covid-19. See this recent paper, highlighted by a Dobber: Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials This analysis concluded “…in comparison to SOC or placebo, IVM did not reduce all-cause mortality, length of stay, respiratory viral clearance, adverse events and serious adverse events in RCTs of patients with mild to moderate COVID-19. We did not find data about IVM effects on clinical improvement and need for mechanical ventilation. Additional ongoing RCTs should be completed in order to update our analyses. In the meanwhile, IVM is not a viable option to treat COVID-19 patients, and only should be used within clinical trials context.”  
Source: Malaysian Medical Resources - Category: International Medicine & Public Health Authors: Tags: Miscellaneous covid-19 ivermectin SARS-cov-2 Source Type: blogs